In the present study, the effect of the IL-1β antagonist in the LT groups without BD was not analyzed, since the investigation is focused on the surgical context of BD+LT, which are the most approximate conditions to what is presented in clinical practice. The gene discussed is IL1B; the disease is Behcet disease.